DLG4 and ischemic stroke: Notably, the therapeutic potential of NA-1 (nerinetide), a peptide fused with TAT that obstructs the interaction of NMDAR with PSD-95, has been satisfactorily tested in patients suffering from ischemic stroke [51, 52].